Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us

 

 


 

Session 90  Poster Abstracts
HIV-1 Neutralizing Antibodies
Wednesday, 1:30 - 3:30 pm
Hall D
    497a Antigenic and Immunogenic Analysis of Hepatitis B Surface Antifgen Particles Containing HIV gp41-Membrane Proximal Region
Sanjay Phogat*1, A Spadaccini2, I Berkower2, and R Wyatt1
1Vaccine Res Ctr, NIAID, NIH, DHHS, Bethesda, MD, USA and 2Center For Biologics, FDA, Bethesda, MD
    497b Use of Directed Molecular Evolution to Create Novel HIV-1 Envelope Variants Capable of Inducing Broadly Neutralizing Antibody Responses in Rabbits
X Du1, L Xu1, W Zhang1, S Tang1, J Harms2, R Robson2, M Chambers2, T Wrin3, C Petropoulos3, M Zwick4, D Burton4, and Robert Whalen*1
1Maxygen Inc, Redwood City, CA, USA; 2Aldevron LLC, Fargo, ND, USA; 3ViroLogic, Inc, South San Francisco, CA, USA; and 4The Scripps Res Inst, La Jolla, CA, USA
      498 Novel Broadly Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected from Phage Display Libraries by Competitive Antigen Panning
Mei-Yun Zhang*1, V Choudhry1, I Sidorov1, S Stefanov1, V Tenev1, C Broder2, and D Dimitrov1
1NCI-Frederick, NIH, DHHS, MD, USA and 2Uniformed Svcs Univ of the Hlth Sci, Bethesda, MD, USA
      499 Antigenic and Immunogenic Properties of Disulfide-stabilized HIV-1 Envelope Trimers
Norbert Schülke*1, S Beddows2, M Franti1, T Zang1, I Vishnefsky1, T Ketas1, K Barnes2, E Michael2, J Moore2, P Maddon1, and W Olson1
1Progenics Pharma, Inc, Tarrytown, NY, USA and 2Weill Med Coll, Cornell Univ, New York, NY, USA
      500

Neutralization and Infectivity Characteristics of Envelope Glycoproteins from Human Immunodeficiency Virus Type 1- infected Donors Whose Sera Exhibit Broadly Cross-reactive Neutralizing Activity
Fatim Cham*1, P Zhang1, L Heyndrickx2, P Bouma1, M Zwick3, D Burton3, H Katinger4, J Robinson5, S Zolla-Pazner6, G van der Groen7, and G Quinnan8
1Uniformed Svcs Univ of the Hlth Sci, Bethesda, MD, USA; 2Inst of Tropical Med, Anwerp, Belgium; 3The Scripps Clin and Res Fndn, La Jolla, CA, USA; 4Inst of Applied Microbiology, Univ of Life Sci, Vienna, Ausria; 5Tulane Univ, New Orleans, LA, USA; 6New York Veterans Admin Med Ctr, NY, USA; 7Inst of Tropical Med, Anwerp, Belgium; and 8Uniformed Svcs Univ of the Hlth Sci, Bethesda, MD, USA